Bexarotene-induced hypothyroidism and dyslipidemia; a nation-wide study-Reference-Cited by-同舟云学术

Bexarotene-induced hypothyroidism and dyslipidemia; a nation-wide study

Published:2024 Issue:8 Volume:71 Page:777-787
ISSN:0918-8959
Container-title:Endocrine Journal
language:en
Short-container-title:Endocr J

Author:

Manaka Katsunori¹,Sato Junichiro¹,Hikima Yusuke¹,Horikoshi Hirofumi¹,Taguchi Maho¹,Morita Akimichi²,Suga Hiraku³,Boki Hikari³,Fujimura Taku⁴,Hirai Yoji⁵,Shimauchi Takatoshi⁶,Tateishi Chiharu⁷,Kiyohara Eiji⁸,Muto Ikko⁹,Nakajima Hideki¹⁰,Abe Riichiro¹¹,Fujii Kazuyasu¹²,Nishigori Chikako¹³,Nakano Eiji¹³,Yonekura Kentaro¹⁴,Funakoshi Takeru¹⁵,Amano Masahiro¹⁶,Miyagaki Tomomitsu¹⁷,Yamashita Reiko¹⁸,Sugaya Makoto¹⁹,Hamada Toshihisa²⁰,Nangaku Masaomi¹,Iiri Taroh²¹,Makita Noriko¹

Affiliation:

1. Division of Nephrology and Endocrinology, Graduate School of Medicine, The University of Tokyo, Tokyo 113-8655, Japan

2. Department of Geriatric and Environmental Dermatology, Nagoya City University Graduate School of Medical Sciences, Nagoya 467-8601, Japan

3. Department of Dermatology, Graduate School of Medicine, The University of Tokyo, Tokyo 113-8655, Japan

4. Department of Dermatology, Tohoku University Graduate School of Medicine, Sendai 980-8575, Japan

5. Department of Dermatology, Dentistry and Pharmaceutical Sciences, Okayama University Graduate School of Medicine, Okayama 700-8558, Japan

6. Department of Dermatology, Hamamatsu University School of Medicine, Hamamatsu 431-3192, Japan

7. Department of Dermatology, Osaka Metropolitan University Graduate School of Medicine, Osaka 545-8586, Japan

8. Department of Dermatology, Course of Integrated Medicine, Graduate School of Medicine, Osaka University, Suita 560-8531, Japan

9. Department of Dermatology, Kurume University School of Medicine, Kurume 830-0011, Japan

10. Department of Dermatology, Kochi Medical School, Kochi University, Nankoku 783-8505, Japan

11. Division of Dermatology, Niigata University Graduate School of Medical and Dental Sciences, Niigata 951-8510, Japan

12. Department of Dermatology, Kagoshima University Graduate School of Medical and Dental Sciences, Kagoshima 890-8544, Japan

13. Division of Dermatology, Kobe University Graduate School of Medicine, Kobe 657-8501, Japan

14. Department of Dermatology, Imamura General Hospital, Kagoshima 890-0064, Japan

15. Department of Dermatology, Keio University School of Medicine, Tokyo 160-8582, Japan

16. Department of Dermatology, Faculty of Medicine, University of Miyazaki, Miyazaki 889-2192, Japan

17. Department of Dermatology, St. Marianna University School of Medicine, Kawasaki 216-8511, Japan

18. Minophagen Pharmaceutical Co., Ltd., Tokyo 160-0023, Japan

19. Department of Dermatology, International University of Health and Welfare, Narita 286-8686, Japan

20. Department of Dermatology, Takamatsu Red Cross Hospital, Takamatsu 760-0017, Japan

21. Department of Pharmacology, St. Marianna University School of Medicine, Kawasaki 216-8511, Japan

Publisher

Japan Endocrine Society

Link

https://www.jstage.jst.go.jp/article/endocrj/71/8/71_EJ23-0699/_pdf

Reference27 articles.

1. 1 Mehta-Shah N, Horwitz SM, Ansell S, Ai WZ, Barnes J, et al. (2020) NCCN guidelines insights: primary cutaneous lymphomas, version 2.2020. J Natl Compr Canc Netw 18: 522–536.

2. 2 Trautinger F, Eder J, Assaf C, Bagot M, Cozzio A, et al. (2017) European organisation for research and treatment of cancer consensus recommendations for the treatment of mycosis fungoides/Sezary syndrome—Update 2017. Eur J Cancer 77: 57–74.

3. 3 Scarisbrick JJ, Morris S, Azurdia R, Illidge T, Parry E, et al. (2013) U.K. consensus statement on safe clinical prescribing of bexarotene for patients with cutaneous T-cell lymphoma. Br J Dermatol 168: 192–200.

4. 4 Makita N, Manaka K, Sato J, Mitani K, Nangaku M, et al. (2019) Bexarotene-induced hypothyroidism: characteristics and therapeutic strategies. Clin Endocrinol (Oxf) 91: 195–200.

5. 5 Sherman SI, Gopal J, Haugen BR, Chiu AC, Whaley K, et al. (1999) Central hypothyroidism associated with retinoid X receptor-selective ligands. N Engl J Med 340: 1075–1079.